Free Trial
NASDAQ:KURA

Kura Oncology (KURA) Stock Price, News & Analysis

Kura Oncology logo
$8.13 -0.30 (-3.56%)
Closing price 04:00 PM Eastern
Extended Trading
$8.32 +0.19 (+2.34%)
As of 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Kura Oncology Stock (NASDAQ:KURA)

Key Stats

Today's Range
$7.90
$8.52
50-Day Range
$5.54
$8.43
52-Week Range
$5.41
$21.40
Volume
1.61 million shs
Average Volume
1.92 million shs
Market Capitalization
$705.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.10
Consensus Rating
Moderate Buy

Company Overview

Kura Oncology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
77th Percentile Overall Score

KURA MarketRank™: 

Kura Oncology scored higher than 77% of companies evaluated by MarketBeat, and ranked 242nd out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Kura Oncology has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 10 buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Kura Oncology has only been the subject of 4 research reports in the past 90 days.

  • Read more about Kura Oncology's stock forecast and price target.
  • Earnings Growth

    Earnings for Kura Oncology are expected to grow in the coming year, from ($2.44) to ($1.72) per share.

  • Price to Book Value per Share Ratio

    Kura Oncology has a P/B Ratio of 1.53. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Kura Oncology's valuation and earnings.
  • Percentage of Shares Shorted

    9.22% of the outstanding shares of Kura Oncology have been sold short.
  • Short Interest Ratio / Days to Cover

    Kura Oncology has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Kura Oncology has recently increased by 1.14%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Kura Oncology does not currently pay a dividend.

  • Dividend Growth

    Kura Oncology does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.22% of the outstanding shares of Kura Oncology have been sold short.
  • Short Interest Ratio / Days to Cover

    Kura Oncology has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Kura Oncology has recently increased by 1.14%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Kura Oncology has a news sentiment score of 1.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Kura Oncology this week, compared to 6 articles on an average week.
  • Search Interest

    10 people have searched for KURA on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Kura Oncology to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
Receive KURA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kura Oncology and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KURA Stock News Headlines

Kura Oncology initiated with a Neutral at Guggenheim
Trump’s national nightmare is here
Washington just added $1 trillion to the national debt in less than two months — an astonishing pace of spending that rivals wartime levels. But according to two veteran analysts, this isn’t recklessness. It’s a deliberate mobilization for what could be America’s most consequential arms race yet. The warning signs are everywhere: ballooning deficits, record shortfalls, and strategic moves to secure resources and manufacturing. If you’ve got money in the market or savings in the bank, understanding what’s happening behind the scenes may be critical.tc pixel
NVIDIA-backed Charm secures $80m to advance AML drug
See More Headlines

KURA Stock Analysis - Frequently Asked Questions

Kura Oncology's stock was trading at $8.71 on January 1st, 2025. Since then, KURA shares have decreased by 6.7% and is now trading at $8.13.

Kura Oncology, Inc. (NASDAQ:KURA) posted its earnings results on Thursday, August, 7th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of $0.15 by $0.90. The business earned $15.29 million during the quarter, compared to analyst estimates of $64.95 million.
Read the conference call transcript
.

Kura Oncology's stock reverse split on Friday, October 18th 2024.The 1-35 reverse split was announced on Monday, October 14th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Kura Oncology's top institutional investors include Armistice Capital LLC (7.14%), EcoR1 Capital LLC (4.84%), Geode Capital Management LLC (2.33%) and Qube Research & Technologies Ltd (2.20%). Insiders that own company stock include Thomas Malley, Teresa Brophy Bair, Mollie Leoni, Thomas James Doyle, Kathleen Ford, Kirsten Flowers and Troy Edward Wilson.
View institutional ownership trends
.

Shares of KURA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kura Oncology investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), Tesla (TSLA), JPMorgan Chase & Co. (JPM) and Walmart (WMT).

Company Calendar

Last Earnings
8/07/2025
Today
9/04/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:KURA
CIK
1422143
Fax
N/A
Employees
130
Year Founded
2007

Price Target and Rating

High Price Target
$40.00
Low Price Target
$10.00
Potential Upside/Downside
+196.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
15 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.26)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$173.98 million
Net Margins
N/A
Pretax Margin
-234.07%
Return on Equity
-52.32%
Return on Assets
-29.59%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
6.16
Quick Ratio
6.16

Sales & Book Value

Annual Sales
$53.88 million
Price / Sales
13.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.52 per share
Price / Book
2.31

Miscellaneous

Outstanding Shares
86,800,000
Free Float
81,242,000
Market Cap
$705.68 million
Optionable
Optionable
Beta
0.19

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:KURA) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners